Vet drugs on marketplaces: niche and leaders analytics
Client:
Vet drugs on WB and Ozon
Segment:
Vet pharma, marketplaces
Result:
688M ₽ niche volume on Wildberries
Direction:
Automation & analytics
The task
The client was preparing to enter Wildberries and Ozon with imported veterinary drugs. The starting point was a purchase list of 84 items from Zoetis, Boehringer, Virbac, Elanco and Dechra.
Before buying, the client needed to know how much money the niche holds, which drugs drive revenue and which of them can be sold legally.
What we did
- Consolidated 84 purchase-list items into 41 drugs: searching by a single dosage gives an incomplete picture.
- Pulled revenue, number of listings and sellers for every drug on Wildberries.
- Checked each drug against the State Register of Medicines for a valid registration certificate.
- Calculated the share of niche revenue that the legal items bring and singled out the sales leaders.
- Brought purchasing, market and sales channels into one table for the launch decision.
Outcome
The Wildberries niche is valued at 688M rubles over 297 days, about 70M rubles a month. Two drugs bring 71% of revenue.
13 drugs with a valid registration bring 91% of the niche's money while making up less than half of the purchase. The client saw what to buy and whom to compete with.
